Cargando…
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
Pancreatic cancer is characterized by mutated signaling pathways and a high incidence of drug resistance. Comprehensive, large-scale proteomic analysis can provide a system-wide view of signaling networks, assist in understanding drug mechanisms of action and interactions, and serve as a useful tool...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827530/ https://www.ncbi.nlm.nih.gov/pubmed/29520231 http://dx.doi.org/10.3389/fphar.2018.00084 |